Close Window
Aetna.com Home    |     Help    |     Contact Us

Search  
Aetna Aetna
Clinical Policy Bulletin:
Gender Reassignment Surgery
Number: 0615


Policy

Note: Most Aetna plans exclude coverage of sex change surgery (gender reassignment surgery, transgender surgery) or any treatment of gender identity disorders.  Please check benefit plan descriptions. 

Aetna considers sex reassignment surgery medically necessary when all of the following criteria are met:

  1. Requirements for mastectomy for female-to-male patients:

    1. Single letter of referral from a qualified mental health professional (see appendix); and
    2. Persistent, well-documented gender identity disorder (see appendix); and
    3. Capacity to make a fully informed decision and to consent for treatment; and
    4. Age of majority (18 years of age or older); and
    5. If significant medical or mental health concerns are present, they must be reasonably well controlled.

    Note that a trial of hormone therapy is not a pre-requisite to qualifying for a mastectomy.

  2. Requirements for gonadectomy (hysterectomy and oophorectomy in female-to-male and orchiectomy in male-to-female):

    1. Two referral letters from qualified mental health professionals, one in a purely evaluative role (see appendix); and
    2. Persistent, well-documented gender identity disorder (see appendix); and
    3. Capacity to make a fully informed decision and to consent for treatment; and
    4. Age of majority (18 years or older); and
    5. If significant medical or mental health concerns are present, they must be reasonably well controlled; and
    6. Twelve months of continuous hormone therapy as appropriate to the member's gender goals (unless the member has a medical contraindication or is otherwise unable or unwilling to take hormones)
  3. Requirements for genital reconstructive surgery (i.e., vaginectomy, urethroplasty, metoidioplasty, phalloplasty, scrotoplasty, and placement of a testicular prosthesis and erectile prosthesis in female to male; penectomy, vaginoplasty, labiaplasty, and clitoroplasty in male to female)

    1. Two referral letters from qualified mental health professionals, one in a purely evaluative role (see appendix); and
    2. Persistent, well-documented gender identity disorder (see appendix); and
    3. Capacity to make a fully informed decision and to consent for treatment; and
    4. Age of majority (age 18 years and older); and
    5. If significant medical or mental health concerns are present, they must be reasonably well controlled; and
    6. Twelve months of continuous hormone therapy as appropriate to the member’s gender goals (unless the member has a medical contraindication or is otherwise unable or unwilling to take hormones); and
    7. Twelve months of living in a gender role that is congruent with their gender identity (real life experience).

Note: Rhinoplasty, face-lifting, lip enhancement, facial bone reduction, blepharoplasty, breast augmentation, liposuction of the waist (body contouring), reduction thyroid chondroplasty, hair removal, voice modification surgery (laryngoplasty or shortening of the vocal cords), and skin resurfacing, which have been used in feminization, are considered cosmetic. Similarly, chin implants, nose implants, and lip reduction, which have been used to assist masculinization, are considered cosmetic.

Note on gender specific services for transgender persons:

Gender-specific services may be medically necessary for transgender persons appropriate to their anatomy. Examples include:

  1. Breast cancer screening may be medically necessary for female to male transgender persons who have not undergone a mastectomy;
  2. Prostate cancer screening may be medically necessary for male to female transgender individuals who have retained their prostate.


Background

Transsexualism is "a gender identity disorder in which the person manifests, with constant and persistent conviction, the desire to live as a member of the opposite sex and progressively take steps to live in the opposite sex role full-time."  People who wish to change their sex may be referred to as "Transsexuals" or as people suffering from "Gender Dysphoria" (meaning unhappiness with one's gender).

Transsexuals usually present to the medical profession with a diagnosis of transsexualism, a sophisticated understanding of their condition, and a desired course of treatment, that is, hormone therapy and sex-reassignment surgery.  The therapeutic approach to gender identity disorder consists of three parts: a real life experience in the desired role, hormones of the desired gender, and surgery to change the genitalia and other sex characteristics (Day, 2002). The most typical order, if all three elements are undertaken, is hormones followed by real life experience and, finally, surgery.

For male to female transsexuals selected for surgery, procedures may include genital reconstruction (vaginoplasty, penectomy, orchidectomy, clitoroplasty), breast augmentation and cosmetic surgery (facial reshaping, rhinoplasty, abdominoplasty, laryngeal shaving, vocal cord shortening, hair transplants) (Day, 2002). For female to male transsexuals, surgical procedures may include genital reconstruction (phalloplasty, genitoplasty, hysterectomy, bilateral oophorectomy), mastectomy, chest wall contouring and cosmetic surgery (Day, 1992).

Due to the far-reaching and irreversible results of hormonal and/or surgical transformational measures, a careful diagnosis and differential diagnosis is absolutely vital to the patient's best interest.  In and of themselves, a patient's self-diagnosis and the intensity of his desire for sex reassignment cannot be viewed as reliable indicators of transsexuality.  A vital part of the long-term diagnostic therapy is the so-called real-life experience, in which the patient lives as a member of the desired sex continually and in all social spheres in order to accumulate necessary experience.  Experience in specialist Gender Identity Units has shown that only about 15% of male transsexuals and 90% of female transsexuals are considered suitable for surgery or still desire it after specialist psychiatric care and a prolonged period of observation used to identify the relatively rare "true" transsexual from the more common "secondary" transsexual.

Hormone therapy and sex-reassignment surgery are superficial changes in comparison to the major psychological adjustments necessary in changing sex.  Treatment should concentrate on the psychological adjustment, with hormone therapy and sex-reassignment surgery being viewed as confirmatory procedures dependent on adequate psychological adjustment.  Psychiatric care may need to be continued for many years after sex-reassignment surgery.  The technical success of sex-reassignment surgery is greater for male-to-female transsexuals than female-to-male transsexuals, and continues to improve as new techniques are developed.  The overall success of treatment depends partly on the technical success of the surgery, but more crucially on the psychological adjustment of the transsexual, and the support from family, friends, employers and the medical profession.

 

Appendix

Table 1: DSM IV-TR criteria for the diagnosis of gender identity disorder in adolescents and adults:

  1. A strong and persistent cross-gender identification (not merely a desire for any perceived cultural advantages of being the other sex).  In adolescents and adults, the disturbance in manifested by symptoms such as a stated desire to be the other sex, frequent passing as the other sex, desire to live or be treated as the other sex, or the conviction that he or she has the typical feelings and reactions of the other sex; and
  2. Persistent discomfort with his or her sex or sense of inappropriateness in the gender role of that sex.  In adolescents and adults, the disturbance is manifested by symptoms such as preoccupation with getting rid of primary and secondary se characteristics (e.g. request for hormones, surgery, or other procedures to physically alter sexual characteristics to simulate the other sex) or belief that he or she was born the wrong sex; and
  3. The disturbance is not concurrent with a physical intersex condition; and
  4. The disturbance causes clinically significant distress or impairment in social, occupational, or other important areas of functioning.

Table 2: Format for referral letters from Qualified Health Professional: (From SOC-7)

  1. Client’s general identifying characteristics; and
  2. Results of the client’s psychosocial assessment, including any diagnoses; and
  3. The duration of the mental health professional’s relationship with the client, including the type of evaluation and therapy or counseling to date; and
  4. An explanation that the WPATH criteria for surgery have been met, and a brief description of the clinical rationale for supporting the patient’s request for surgery; and
  5. A statement about the fact that informed consent has been obtained from the patient; and
  6. A statement that the mental health professional is available for coordination of care and welcomes a phone call to establish this.

Note:  There is no minimum duration of relationship required with mental health professional.  It is the professional’s judgment as to the appropriate length of time before a referral letter can appropriately be written.  A common period of time is three months, but there is significant variation in both directions.  When two letters are required, the second referral is intended to be an evaluative consultation, not a representation of an ongoing long-term therapeutic relationship, and can be written by a medical practitioner of sufficient experience with gender dysphoria.

Note: Evaluation of candidacy for sex reassignment surgery by a mental health professional is covered under the member’s medical benefit, unless the services of a mental health professional are necessary to evaluate and treat a mental health problem, in which case the mental health professional’s services are covered under the member’s behavioral health benefit. Please check benefit plan descriptions.

Table 3: Characteristics of a Qualified Mental Health Professional: (From SOC-7):

  1. Master’s degree or equivalent in a clinical behavioral science field granted by an institution accredited by the appropriate national accrediting board.  The professional should also have documented credentials from the relevant licensing board or equivalent; and
  2. Competence in using the Diagnostic Statistical Manual of Mental Disorders and/or the International Classification of Disease for diagnostic purposes; and
  3. Ability to recognize and diagnose co-existing mental health concerns and to distinguish these from gender dysphoria; 
  4. Knowledgeable about gender nonconforming identities and expressions, and the assessment and treatment of gender dysphoria; and
  5. Continuing education in the assessment and treatment of gender dysphoria.  This may include attending relevant professional meetings, workshops, or seminars; obtaining supervision from a mental health professional with relevant experience; or participating in research related to gender nonconformity and gender dysphoria. 
 
CPT Codes / HCPCS Codes / ICD-9 Codes
CPT codes covered if selection criteria are met:
19301, 19303 - 19304
53430
54125
54400 - 54417
54520
54660
54690
55175
55180
55970
55980
56625
56800
56805
56810
57106 - 57107, 57110 - 57111
57291 - 57292
57335
58150, 58180, 58260 - 58262, 58275 - 58291, 58541 - 58544, 58550 - 58554
58570 - 58573
58661
58720
CPT codes not covered for indications listed in the CPB [considered cosmetic]:
11950 - 11954
15780 - 15787
15788 - 15793
15820 - 15823
15824 - 15828
15830 - 15839
15876 - 15879
17380
19316
19318
19324 - 19325
19340
19342
19350
21120 - 21123
21125 - 21127
30400 - 30420
30430 - 30450
Other CPT codes related to the CPB:
90785
90832 - 90838
ICD-9 codes covered if selection criteria are met:
302.50 - 302.53 Trans-sexualism
302.85 Gender identity disorder in adolescents or adults
ICD-9 codes not covered for indications listed in the CPB:
293.0 - 302.4, 302.6 - 302.84, 302.89 - 319 Mental disorders [other than transexualism and gender identity disorder]
752.7 Indeterminate sex and pseudohermaphroditism
758.0 - 758.9 Chromosomal anomalies


The above policy is based on the following references:
  1. Becker S, Bosinski HA, Clement U, et al. Standards for treatment and expert opinion on transsexuals. The German Society for Sexual Research, The Academy of Sexual medicine and the Society for Sexual Science. Fortschr Neurol Psychiatr. 1998;66(4):164-169.
  2. Standards of care: The hormonal and surgical sex reassignment of gender dysphoric persons. Harry Benjamin International Gender Dysphoria Association. Arch Sex Behav. 1985;14(1):79-90 and (Fifth Version) June 15, 1998.
  3. Landen M, Walinder J, Lundstrom B. Clinical characteristics of a total cohort of female and male applicants for sex reassignment: A descriptive study. Acta Psychiatr Scand. 1998;97(3):189-194.
  4. Schlatterer K, Yassouridis A, von Werder K, et al. A follow-up study for estimating the effectiveness of a cross-gender hormone substitution therapy on transsexual patients. Arch Sex Behav. 1998;27(5):475-492.
  5. Midence K, Hargreaves I. Psychosocial adjustment in male-to-female transsexuals: An overview of the research evidence. J Psychol. 1997;131(6):602-614.
  6. van Kesteren PJ, Asscheman H, Megens JA, et al. Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clin Endocrinol (Oxf). 1997;47(3):337-342.
  7. Eldh J, Berg A, Gustafsson M. Long-term follow up after sex reassignment surgery. Scand J Plast Reconstr Surg Hand Surg. 1997;31(1):39-45.
  8. Bradley SJ, Zucker KJ. Gender identity disorder: A review of the past 10 years. J Am Acad Child Adolesc Psychiatry. 1997;36(7):872-880.
  9. Luton JP, Bremont C. The place of endocrinology in the management of transsexualism. Bull Acad Natl Med. 1996;180(6):1403-1407.
  10. Beemer BR. Gender dysphoria update. J Psychosoc Nurs Ment Health Serv. 1996;34(4):12-19.
  11. Schlatterer K, von Werder K, Stalla GK. Multistep treatment concept of transsexual patients. Exp Clin Endocrinol Diabetes. 1996;104(6):413-419.
  12. Breton J, Cordier B. Psychiatric aspects of transsexualism. Bull Acad Natl Med. 1996;180(6):1389-1393; discussion 1393-1394.
  13. Hage JJ. Medical requirements and consequences of sex reassignment surgery. Med Sci Law. 1995;35(1):17-24.
  14. Cole CM, Emory LE, Huang T, et al. Treatment of gender dysphoria (transsexualism). Tex Med. 1994;90(5):68-72.
  15. Snaith RP, Hohberger AD. Transsexualism and gender reassignment. Br J Psychiatry. 1994;165(3):418-419.
  16. Cohen-Kettenis PT, Kuiper AJ, Zwaan WA, et al. Transsexualism. II. Diagnosis: The initial, tentative phase. Ned Tijdschr Geneeskd. 1992;136(39):1895-1897.
  17. Brown GR. A review of clinical approaches to gender dysphoria. J Clin Psychiatry. 1990;51(2):57-64.
  18. Mate-Kole C. Sex reassignment surgery. Br J Hosp Med. 1989;42(4):340.
  19. Gooren LJ. Transsexualism. I. Description, etiology, management. Ned Tijdschr Geneeskd. 1992;136(39):1893-1895.
  20. Petersen ME, Dickey R. Surgical sex reassignment: A comparative survey of international centers. Arch Sex Behav. 1995;24(2):135-156.
  21. Alberta Heritage Foundation for Medical Research (AHFMR). Phalloplasty in female-male transsexuals. Technote TN 6. Edmonton, AB: AHFMR; 1996. Available at: http://www.crd.york.ac.uk/crdweb/ShowRecord.asp?View=Full&ID=31998008919. Accessed June 30, 2010.
  22. Alberta Heritage Foundation for Medical Research (AHFMR). Vaginoplasty in male-female transsexuals and criteria for sex reassignment surgery. Technote TN 7. Edmonton, AB: AHFMR; 1997. Available at: http://www.crd.york.ac.uk/CRDWeb/ShowRecord.asp?ID=31998008920. Accessed June 30, 2010.
  23. Best L, Stein K. Surgical gender reassignment for male to female transsexual people. DEC Report No. 88. Southampton, UK: Wessex Institute for Health Research and Development, University of Southampton; 1998. Available at: http://www.hta.ac.uk/rapidhta/publications/dec88.pdf. Accessed June 30, 2010.
  24. Smith YL, Cohen L, Cohen-Kettenis PT. Postoperative psychological functioning of adolescent transsexuals: A Rorschach study. Arch Sex Behav. 2002;31(3):255-261.
  25. Day P. Trans-gender reassignment surgery. NZHTA Tech Brief Series. Christchurch, New Zealand: New Zealand Health Technology Assessment (NZHTA); 2002;1(1). Available at: http://nzhta.chmeds.ac.nz/publications/trans_gender.pdf. Accessed June 30, 2010.
  26. Lawrence AA, Latty EM, Chivers ML, Bailey JM. Measurement of sexual arousal in postoperative male-to-female transsexuals using vaginal photoplethysmography. Arch Sex Behav. 2005;34(2):135-145.
  27. Meyer W, Bockting W, Cohen-Kettenis P, et al.; Harry Benjamin International Gender Dysphoria Association. The standards of care for gender identity disorders -- Sixth version. Int J Transgenderism. 2001;5(1). Available at: http://www.wpath.org/Documents2/socv6.pdf. Accessed June 30, 2010.
  28. Lawrence AA. Factors associated with satisfaction or regret following male-to-female sex reassignment surgery. Arch Sex Behav. 2003;32(4):299-315.
  29. Tugnet N, Goddard JC, Vickery RM, et al.  Current management of male-to-female gender identity disorder in the UK. Postgrad Med J. 2007;83(984):638-642.
  30. Sutcliffe PA, Dixon S, Akehurst RL, et al. Evaluation of surgical procedures for sex reassignment: A systematic review. J Plast Reconstr Aesthet Surg. 2009;62(3):294-306; discussion 306-308.
  31. Tønseth KA, Bjark T, Kratz G, et al. Sex reassignment surgery in transsexuals. Tidsskr Nor Laegeforen. 2010;130(4):376-379.
  32. Hembree et al. Endocrine Treatment of Transsexual Persons:  An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. Sept 2009, 94(9):3132-3154.
  33. Meriggiola MC, Jannini EA, Lenzi A, et al. Endocrine treatment of transsexual persons: An Endocrine Society Clinical Practice Guideline: Commentary from a European perspective. Eur J Endocrinol. 2010;162(5):831-833.
  34. UK National Health Service (NHS), Oxfordshire Primary Care Trust, South Central Priorities Committee. Treatments for gender dysphoria. Policy Statement 18c. Ref TV63. Oxford, UK: NHS; updated September 2009.
  35. Standards of Care for the Health of Transsexual, Transgender, and Gender Nonconforming People, Version 7, World Professional Association for Transgender Health. http://www.wpath.org/publications_standards.cfm


email this page   


Copyright Aetna Inc. All rights reserved. Clinical Policy Bulletins are developed by Aetna to assist in administering plan benefits and constitute neither offers of coverage nor medical advice. This Clinical Policy Bulletin contains only a partial, general description of plan or program benefits and does not constitute a contract. Aetna does not provide health care services and, therefore, cannot guarantee any results or outcomes. Participating providers are independent contractors in private practice and are neither employees nor agents of Aetna or its affiliates. Treating providers are solely responsible for medical advice and treatment of members. This Clinical Policy Bulletin may be updated and therefore is subject to change.
Aetna
Back to top